Intravesical BCG and second primary malignancies.
Khanna
O P
OP
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D006801:Humans; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D001500:BCG Vaccine